Phase III randomized trial comparing weekly vs. standard schedules of paclitaxel (P) plus carboplatin (C) for advanced non-small cell lung cancer (NSCLC): Analyses of elderly patients

被引：2
|
作者：
Belani, C
Ramalingam, S
Perry, M
LaRocca, R
Rinaldi, D
Gable, P
Tester, W
机构：
[1] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA
[2] Univ Missouri, Ellis Fischel Canc Ctr, Columbia, MO USA
[3] Kentuckiana Canc Ctr, Louisville, KY USA
[4] Louisiana Oncol Associates, Iberia, LA USA
[5] Albert Einstein Med Ctr, Philadelphia, PA 19141 USA
来源：
LUNG CANCER | 2005年 / 49卷
关键词：
D O I：
10.1016/S0169-5002(05)80222-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S32 / S32
页数：1
相关论文
共 50 条
  • [1] Outcome of elderly (≥70 years) non-small cell lung cancer (NSCLC) patients on a multicenter, phase III randomized trial comparing weekly vs. standard schedules of paclitaxel (P) plus carboplatin (C).
    Ramalingam, S
    Perry, MC
    Larocca, RV
    Rinaldi, DA
    Gable, P
    Tester, WJ
    Belani, CP
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 657S - 657S
  • [2] A phase II trial of weekly paclitaxel and carboplatin for elderly patients with advanced non-small cell lung cancer (NSCLC).
    Usui, K
    Inoue, A
    Ishimoto, O
    Tanaka, M
    Koinumaru, S
    Matsubara, N
    Kanbe, M
    Gomi, K
    Saijo, Y
    Nukiwa, T
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 682S - 682S
  • [3] Randomized, phase II trial comparing carboplatin (C) and tri-weekly paclitaxel (tP) with C and weekly paclitaxel (wP) in elderly patients (pts) with advanced non-small cell lung cancer (NSCLC)
    Maemondo, M.
    Inoue, A.
    Sugawara, S.
    Ishida, T.
    Usui, K.
    Abe, T.
    Kanbe, M.
    Watanabe, H.
    Saijo, Y.
    Nukiwa, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [4] A randomized phase III trial comparing bexarotene/carboplatin/paclitaxel versus carboplatin/paclitaxel in chemotherapy-naive patients with advanced or metastatic non-small cell lung cancer (NSCLC).
    Blumenschein, GR
    Khuri, F
    Gatzemeier, U
    Miller, WH
    von Pawel, J
    Rigas, JR
    Herbst, RS
    Dziewanowska, Z
    Negro-Vilar, A
    Mabry, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 1094S - 1094S
  • [5] Randomized Phase II Trial Comparing Carboplatin Plus Weekly Paclitaxel and Docetaxel Alone in Elderly Patients With Advanced Non-Small Cell Lung Cancer: North Japan Lung Cancer Group Trial 0801
    Maemondo, Makoto
    Inoue, Akira
    Sugawara, Shunichi
    Harada, Toshiyuki
    Minegishi, Yuji
    Usui, Kazuhiro
    Miwa, Koji
    Morikawa, Naoto
    Kambe, Mariko
    Ube, Kenji
    Watanabe, Kana
    Ishimoto, Osamu
    Sakakibara, Tomohiro
    Gemma, Akihiko
    Nukiwa, Toshihiro
    ONCOLOGIST, 2014, 19 (04): : 352 - 353
  • [6] Randomized phase II trial of weekly paclitaxel combined with carboplatin versus standard paclitaxel combined with carboplatin for elderly patients with advanced non-small-cell lung cancer
    Sakakibara, T.
    Inoue, A.
    Sugawara, S.
    Maemondo, M.
    Ishida, T.
    Usui, K.
    Abe, T.
    Kanbe, M.
    Watanabe, H.
    Saijo, Y.
    Nukiwa, T.
    ANNALS OF ONCOLOGY, 2010, 21 (04) : 795 - 799
  • [7] Paclitaxel and gemcitabine vs carboplatin and gemcitabine. A multicenter, phase III randomized trial in patients with advanced inoperable non-small cell lung cancer (NSCLC)
    Kosmidis, PA
    Kalofonos, C
    Syrigos, K
    Skarlos, D
    Fountzilas, G
    Nicolaides, C
    Bafaloukos, D
    Samantas, E
    Bakogiannis, C
    Dimopoulos, AM
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 621S - 621S
  • [8] Paclitaxel and gemcitabine vs carboplatin and gemcitabine. A multicenter, phase III randomized trial in patients with advanced inoperable non-small cell lung cancer (NSCLC)
    Kosmidis, P
    Kalofonos, C
    Syrigos, K
    Skarlos, D
    Fountzilas, G
    Nicolaides, C
    Bafaloukos, D
    Samantas, E
    Bakogiannis, C
    Dimopoulos, A
    LUNG CANCER, 2005, 49 : S34 - S34
  • [9] A randomized phase III trial comparing ionafarnib/carboplatin/paclitaxel versus carboplatin/paclitaxel (CP) in chemotherapy-naive patients with advanced or metastatic non-small cell lung cancer (NSCLC)
    Blumenschein, G
    Ludwig, C
    Thomas, G
    Tan, E
    Fanucchi, M
    Santoro, A
    Crawford, J
    Breton, J
    O'Brien, M
    Khuri, F
    LUNG CANCER, 2005, 49 : S30 - S30
  • [10] Weekly paclitaxel (P) in patients with advanced non-small cell lung cancer (NSCLC).
    Nakagawa, K
    Fukuoka, M
    Saijo, N
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 704S - 704S
12345